Envoy Medical appointed Robert Potashnick as Chief Accounting Officer and Vice President of Finance effective August 24, 2026. Mr. Potashnick receives a $315,000 annual base salary, a target bonus equal to 15% of base salary, and an initial equity award of 250,000 stock options at an exercise price of $0.746 per share. He previously served as the company's interim CFO on a contractor basis since June 2025. Envoy Medical develops and manufactures minimally invasive surgical devices for ear, nose, and throat procedures.

Envoy Medical, Inc. reported financial results for the second quarter ended June 30, 2026, including net revenue of $51,000 and a net loss attributable to common stockholders of $7,272,000, or $0.07 per share. The company submitted the first module of its modular Premarket Approval application for the Acclaim cochlear implant to the FDA and reported positive 12-month clinical data showing improved speech perception in early trial participants. Additionally, Envoy Medical terminated its at-the-market equity offering program, which had authorized up to $15 million in sales. As of June 30, 2026, the company held approximately $19.7 million in cash. Envoy Medical operates in the hearing health industry, developing and commercializing fully implanted medical devices for hearing loss.

Envoy Medical, Inc. terminated its At The Market Offering Agreement dated January 17, 2025, on June 24, 2026. Envoy Medical, Inc. is a medical device company that develops and manufactures specialized respiratory-related medical devices.

Envoy Medical, Inc. announced on June 19, 2026, that its Compensation Committee approved an updated base salary of $420,000 and a $105,000 target cash bonus for CEO Brent Lucas. The Committee also granted 1,000,000 stock options with an exercise price of $0.634 per share and 1,000,000 restricted stock units (RSUs) that vest upon FDA approval of the Acclaim cochlear implant between 06/19/2026 and 06/18/2030. Envoy Medical, Inc. operates in the medical device industry and develops cochlear implant technology.